Morning dosing for dolutegravir-related insomnia and sleep disorders

HIV Med. 2018 May;19(5):e62-e63. doi: 10.1111/hiv.12540. Epub 2017 Aug 1.

Authors

A F Capetti¹, S Di Giambenedetto², A Latini³, G Sterrantino⁴, I De Benedetto⁵, M V Cossu¹, A Gori⁵

Affiliations

¹ Ospedale Luigi Sacco-Polo Universitario, Milano, Lombardia, Italy.
² 2Â° Divisione di Malattie Infettive, UniversitÃ Cattolica del Sacro Cuore, Roma, Italy.
³ Unit of Infectious Dermatology, San Gallicano Hospital, Rome, Italy.
⁴ Infectious Diseases Unit, Careggi University Hospital, Florence, Italy.
⁵ Azienda Ospedaliera San Gerardo, Monza, Lombardia, Italy.

PMID: 28762661
DOI: 10.1111/hiv.12540

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
HIV Infections*
Heterocyclic Compounds, 3-Ring
Humans
Oxazines
Piperazines
Pyridones
Sleep Initiation and Maintenance Disorders*

Substances

Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
dolutegravir